• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤溶失调趋势:损伤后数天内纤溶功能关闭与严重受伤儿童的不良预后相关。

Trending Fibrinolytic Dysregulation: Fibrinolysis Shutdown in the Days After Injury Is Associated With Poor Outcome in Severely Injured Children.

作者信息

Leeper Christine M, Neal Matthew D, McKenna Christine J, Gaines Barbara A

机构信息

*Division of General Surgery and Trauma, Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA †Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA.

出版信息

Ann Surg. 2017 Sep;266(3):508-515. doi: 10.1097/SLA.0000000000002355.

DOI:10.1097/SLA.0000000000002355
PMID:28650356
Abstract

OBJECTIVE

To trend fibrinolysis after injury and determine the influence of traumatic brain injury (TBI) and massive transfusion on fibrinolysis status.

BACKGROUND

Admission fibrinolytic derangement is common in injured children and adults, and is associated with poor outcome. No studies examine fibrinolysis days after injury.

METHODS

Prospective study of severely injured children at a level 1 pediatric trauma center. Rapid thromboelastography was obtained on admission and daily for up to 7 days. Standard definitions of hyperfibrinolysis (HF; LY30 ≥3), fibrinolysis shutdown (SD; LY30 ≤0.8), and normal (LY30 = 0.9-2.9) were applied. Antifibrinolytic use was documented. Outcomes were death, disability, and thromboembolic complications. Wilcoxon rank-sum and Fisher exact tests were performed. Exploratory subgroups included massively transfused and severe TBI patients.

RESULTS

In all, 83 patients were analyzed with median (interquartile ranges) age 8 (4-12) and Injury Severity Score 22 (13-34), 73.5% blunt mechanism, 47% severe TBI, 20.5% massively transfused. Outcomes were 14.5% mortality, 43.7% disability, and 9.8% deep vein thrombosis. Remaining in or trending to SD was associated with death (P = 0.007), disability (P = 0.012), and deep vein thrombosis (P = 0.048). Median LY30 was lower on post-trauma day (PTD)1 to PTD4 in patients with poor compared with good outcome; median LY30 was lower on PTD1 to PTD3 in TBI patients compared with non-TBI patients. HF without associated shutdown was not related to poor outcome, but extreme HF (LY30 >30%, n = 3) was lethal. Also, 50% of massively transfused patients in hemorrhagic shock demonstrated SD physiology on admission. All with HF (fc31.2%) corrected after hemostatic resuscitation without tranexamic acid.

CONCLUSIONS

Fibrinolysis shutdown is common postinjury and predicts poor outcomes. Severe TBI is associated with sustained shutdown. Empiric antifibrinolytics for children should be questioned; thromboelastography-directed selective use should be considered for documented HF.

摘要

目的

追踪损伤后的纤溶情况,并确定创伤性脑损伤(TBI)和大量输血对纤溶状态的影响。

背景

入院时纤溶紊乱在受伤儿童和成人中很常见,且与不良预后相关。尚无研究考察损伤后数天的纤溶情况。

方法

对一家一级儿童创伤中心的重伤儿童进行前瞻性研究。入院时及之后每天进行快速血栓弹力图检查,持续7天。采用高纤溶(HF;LY30≥3)、纤溶停止(SD;LY30≤0.8)和正常(LY30 = 0.9 - 2.9)的标准定义。记录抗纤溶药物的使用情况。结局指标为死亡、残疾和血栓栓塞并发症。进行Wilcoxon秩和检验和Fisher精确检验。探索性亚组包括大量输血患者和重度TBI患者。

结果

共分析了83例患者,中位(四分位间距)年龄8(4 - 12)岁,损伤严重度评分22(13 - 34),73.5%为钝性机制损伤,47%为重度TBI,20.5%大量输血。结局为14.5%死亡,43.7%残疾,9.8%发生深静脉血栓形成。持续处于或趋向于SD与死亡(P = 0.007)、残疾(P = 0.012)和深静脉血栓形成(P = 0.048)相关。预后不良患者创伤后第1天(PTD)至第4天的中位LY30低于预后良好患者;TBI患者PTD1至PTD3的中位LY30低于非TBI患者。无相关纤溶停止的HF与不良预后无关,但极重度HF(LY30>30%,n = 3)是致命的。此外,出血性休克中50%的大量输血患者入院时表现为SD生理状态。所有HF患者(占31.2%)在止血复苏且未使用氨甲环酸后纤溶情况得到纠正。

结论

纤溶停止在损伤后很常见,并预示不良预后。重度TBI与持续性纤溶停止相关。儿童经验性使用抗纤溶药物应受到质疑;对于记录有HF的情况,应考虑根据血栓弹力图指导进行选择性使用。

相似文献

1
Trending Fibrinolytic Dysregulation: Fibrinolysis Shutdown in the Days After Injury Is Associated With Poor Outcome in Severely Injured Children.纤溶失调趋势:损伤后数天内纤溶功能关闭与严重受伤儿童的不良预后相关。
Ann Surg. 2017 Sep;266(3):508-515. doi: 10.1097/SLA.0000000000002355.
2
Abnormalities in fibrinolysis at the time of admission are associated with deep vein thrombosis, mortality, and disability in a pediatric trauma population.入院时纤溶异常与小儿创伤患者的深静脉血栓形成、死亡率和残疾相关。
J Trauma Acute Care Surg. 2017 Jan;82(1):27-34. doi: 10.1097/TA.0000000000001308.
3
Window of Opportunity to Mitigate Trauma-induced Coagulopathy: Fibrinolysis Shutdown not Prevalent Until 1 Hour Post-injury.创伤后凝血病的治疗时机窗口:纤溶抑制直至损伤后 1 小时才普遍出现。
Ann Surg. 2019 Sep;270(3):528-534. doi: 10.1097/SLA.0000000000003464.
4
Overresuscitation with plasma is associated with sustained fibrinolysis shutdown and death in pediatric traumatic brain injury.在小儿创伤性脑损伤中,血浆过度复苏与持续的纤维蛋白溶解抑制和死亡有关。
J Trauma Acute Care Surg. 2018 Jul;85(1):12-17. doi: 10.1097/TA.0000000000001836.
5
Prevalence and impact of admission hyperfibrinolysis in severely injured pediatric trauma patients.严重受伤的儿科创伤患者入院时高纤溶状态的患病率及影响
Surgery. 2015 Sep;158(3):812-8. doi: 10.1016/j.surg.2015.05.004. Epub 2015 Jun 10.
6
Persistent Fibrinolysis Shutdown Is Associated with Increased Mortality in Severely Injured Trauma Patients.持续性纤维蛋白溶解功能关闭与严重创伤患者死亡率增加相关。
J Am Coll Surg. 2017 Apr;224(4):575-582. doi: 10.1016/j.jamcollsurg.2016.12.018. Epub 2016 Dec 23.
7
Increased risk of fibrinolysis shutdown among severely injured trauma patients receiving tranexamic acid.严重创伤患者接受氨甲环酸治疗后纤溶抑制的风险增加。
J Trauma Acute Care Surg. 2018 Mar;84(3):426-432. doi: 10.1097/TA.0000000000001792.
8
Analysis of fibrinolytic shutdown in trauma patients with traumatic brain injury.创伤性脑损伤的创伤患者纤溶功能关闭的分析。
Am J Surg. 2024 Jan;227:72-76. doi: 10.1016/j.amjsurg.2023.09.034. Epub 2023 Sep 26.
9
Principal component analysis of coagulation assays in severely injured children.严重创伤患儿凝血检测的主成分分析。
Surgery. 2018 Apr;163(4):827-831. doi: 10.1016/j.surg.2017.09.031. Epub 2017 Dec 13.
10
The hyperfibrinolytic phenotype is the most lethal and resource intense presentation of fibrinolysis in massive transfusion patients.高纤溶表型是大量输血患者中最致命且资源消耗巨大的纤溶表现形式。
J Trauma Acute Care Surg. 2018 Jan;84(1):25-30. doi: 10.1097/TA.0000000000001699.

引用本文的文献

1
Impact of early plasma resuscitation in pediatric severe traumatic brain injury.早期血浆复苏对小儿重度创伤性脑损伤的影响。
J Pediatr Surg. 2025 Aug 5;60(10):162500. doi: 10.1016/j.jpedsurg.2025.162500.
2
SHock-INduced Endotheliopathy (SHINE): A mechanistic justification for viscoelastography-guided resuscitation of traumatic and non-traumatic shock.休克诱导的内皮病变(SHINE):创伤性和非创伤性休克粘弹性成像引导复苏的机制依据
Front Physiol. 2023 Feb 27;14:1094845. doi: 10.3389/fphys.2023.1094845. eCollection 2023.
3
Fibrinolysis resistance after liver transplant as a predictor of early infection.
肝移植后纤维蛋白溶解抵抗作为早期感染的预测因子。
Am J Surg. 2022 Dec;224(6):1455-1459. doi: 10.1016/j.amjsurg.2022.09.011. Epub 2022 Sep 13.
4
Endotheliopathy is Associated with a 24-hour Fibrinolysis Phenotype Described by Low TEG Lysis and High D-Dimer after Trauma: a Secondary Analysis of the PROPPR Study.内皮病变与创伤后低血栓弹力图溶解率和高D-二聚体所描述的24小时纤维蛋白溶解表型相关:PROPPR研究的二次分析
Ann Surg Open. 2022 Mar;3(1). doi: 10.1097/as9.0000000000000116.
5
Trauma-induced coagulopathy.创伤性凝血病。
Nat Rev Dis Primers. 2021 Apr 29;7(1):30. doi: 10.1038/s41572-021-00264-3.
6
Early abnormal fibrinolysis and mortality in patients with thermal injury: a prospective cohort study.热烧伤患者早期异常纤溶与死亡率:一项前瞻性队列研究。
BJS Open. 2021 Mar 5;5(2). doi: 10.1093/bjsopen/zrab017.
7
Impact of a clinical pharmacist on ultrasound-guided venous thromboembolism screening in hospitalized COVID-19 patients: a pilot prospective study.临床药剂师对住院COVID-19患者超声引导下静脉血栓栓塞筛查的影响:一项前瞻性试点研究。
J Pharm Health Care Sci. 2021 Apr 1;7(1):19. doi: 10.1186/s40780-021-00201-2.
8
Use of viscoelastic monitoring and prothrombin complex concentrate in a paediatric patient with polytrauma and severe traumatic brain injury.在一名患有多发伤和严重颅脑外伤的儿科患者中使用粘弹性监测和凝血酶原复合物浓缩物。
BMJ Case Rep. 2020 Dec 13;13(12):e236608. doi: 10.1136/bcr-2020-236608.
9
A rat model of orthopedic injury-induced hypercoagulability and fibrinolytic shutdown.骨科损伤诱导的高凝状态和纤维蛋白溶解抑制的大鼠模型。
J Trauma Acute Care Surg. 2020 Nov;89(5):926-931. doi: 10.1097/TA.0000000000002924.
10
Study of alteplase for respiratory failure in severe acute respiratory syndrome coronavirus 2/COVID-19: Study design of the phase IIa STARS trial.阿替普酶治疗严重急性呼吸综合征冠状病毒2/新型冠状病毒肺炎所致呼吸衰竭的研究:IIa期STARS试验的研究设计
Res Pract Thromb Haemost. 2020 Aug 19;4(6):984-996. doi: 10.1002/rth2.12395. eCollection 2020 Aug.